Market Research Report

A quick peek into the report

Asia-Pacific and Middle East NGS Market

Focus on Offering, Platform, Throughput, Technology Type, Application, End User, and Country Analysis - Analysis and Forecast, 2022-2027

Some Faq's

Frequently Asked Questions

Next generation sequencing (NGS) is a ‘high-throughput method used to determine a portion of the nucleotide sequence of an individual’s genome. This technique utilizes DNA sequencing technologies that are capable of processing multiple DNA sequences in parallel.’

According to BIS Research, NGS products consist of consumables, equipment (NGS platforms), and services offered by various genome sequencing companies.

Synergistic activities and product launches/approvals accounted for the maximum number of key developments, i.e., over 70% of the total developments in the global Asia-Pacific and Middle East NGS market. Key players such as illumina, Inc. and Thermo Fisher Scientific Inc. are involved in launching new technologically advanced NGS platforms and engaging in synergistic partnerships to gain further market share.

• Supply chain analysis

• Impact of COVID-19

• Region-level market segmentation by offerings, platform, throughput, technology, end user, and application

· Country-level market segmentation by platform and offerings

Genomic sequencing and life science companies as well as startups looking to enter the NGS market should buy this report

Similar Product

You may also like

Next Generation Sequencing (NGS) Market - A Global and Regional Analysis
Published Year: 2023

Next Generation Sequencing (NGS) Market - A Global and Regional Analysis: Focus on Offering, Company

The global NGS market was valued at $6.76 billion in 2022 and is expected to reach $28.47...